Delivery Order SPE2DB22D2206-SPE2DB23FKK69
Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $649.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligram/0.9 milliliter syringes of Actemra. The single day contract has a period of performance from July 20, 2023 through July 21, 2023 and will be performed in Conshohocken, Pennsylvania. Actemra is a brand name biologic approved for the treatment of rheumatoid arthritis and other autoimmune conditions. This delivery order was issued under an...
- The Defense Logistics Agency awarded a $11,519.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligrams per 0.9 milliliter syringes of Actemra. Actemra is a brand name biologic medication used to treat conditions such as rheumatoid arthritis. The place of performance for this contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 23, 2023 through August 24, 2023. No major...
- The Defense Logistics Agency awarded a $11,363 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 4561401397 units of the specified medication. Performance will take place in Conshohocken, Pennsylvania over a three-day period from July 3 to July 5, 2023. As the DLA supports military treatment...
- The Defense Logistics Agency awarded a $15,594 delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to support Department of Defense requirements. The firm fixed price order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance concluding on July 31, 2023. No subcontractors or set-aside designations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $11,411.43 under a firm fixed-price contract. The delivery order is non-set-aside and carries an ultimate completion date of September 4, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $5,532 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The single delivery order is for pharmaceutical products to support Department of Defense health programs and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by August 28, 2023. No set aside designation or subcontractors were identified for this small purchase to meet short-term DLA requirements for an...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a $2,877.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a delivery order valued at $8,134.65 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This firm fixed-price, non-set-aside delivery order was awarded on January 6, 2026, with a completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used primarily for rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a $5,761.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of ACTEMRA 162 mg/0.9 mL syringes. The award, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending...